Evidence map›Paper›PMID 23300522›Full record

ArticlePloS one2012

Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.

Basak Isin, Guillermina Estiu, Olaf Wiest, Zoltán N Oltvai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Benchmarking pJournal of chemical information and modeling · 2026
    Article
  2. Article
  3. Molecular evolution of octopamine receptors inbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. 17β-Estradiol Concentration and Direct βAnnals of neurosciences · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Oxidative cyclizations in orthosomycin biosynthesis expand the known chemistry of an oxygenase superfamily.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Basak IsinDepartment of Pathology, University of Pittsburgh, Pittsburgh, PA, USA. bai2@pitt.edu
Guillermina Estiu
Olaf Wiest
Zoltán N Oltvai
University of Pittsburgh · USPeking University · CNUniversity of Notre Dame · US

Funding

PHS HHS U01-0700499
6 · The paper itself

Abstract

Recently available G-protein coupled receptor (GPCR) structures and biophysical studies suggest that the difference between the effects of various agonists and antagonists cannot be explained by single structures alone, but rather that the conformational ensembles of the proteins need to be considered. Here we use an elastic network model-guided molecular dynamics simulation protocol to generate an ensemble of conformers of a prototypical GPCR, β(2)-adrenergic receptor (β(2)AR). The resulting conformers are clustered into groups based on the conformations of the ligand binding site, and distinct conformers from each group are assessed for their binding to known agonists of β(2)AR. We show that the select ligands bind preferentially to different predicted conformers of β(2)AR, and identify a role of β(2)AR extracellular region as an allosteric binding site for larger drugs such as salmeterol. Thus, drugs and ligands can be used as "computational probes" to systematically identify protein conformers with likely biological significance.

Indexed as

Molecular Dynamics SimulationAdrenergic beta-2 Receptor AgonistsAlbuterolAllosteric SiteBinding SitesCrystallography, X-RayHumansModels, MolecularNuclear Magnetic Resonance, BiomolecularProtein BindingProtein ConformationReceptors, Adrenergic, beta-2Salmeterol XinafoateThermodynamicsADRB2 protein, humanAdrenergic beta-2 Receptor AgonistsAlbuterolReceptors, Adrenergic, beta-2Salmeterol Xinafoate

Identifiers

PMID23300522
PMCPMC3534076
OpenAlexW2151652273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.